Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


The Angels Initiative

Stroke prevention


  Ischemic Heart Disease

  Free Subscription


09.05.2022

1 AJR Am J Roentgenol
1 Am Heart J
3 Am J Cardiol
1 Am J Emerg Med
6 Angiology
2 Ann Thorac Surg
5 Atherosclerosis
3 BMJ
2 Circ Heart Fail
1 Circulation
2 Crit Care Med
1 Eur Heart J
7 Int J Cardiol
2 J Am Coll Cardiol
4 J Cardiovasc Pharmacol
1 J Clin Epidemiol
1 J Clin Invest
5 J Electrocardiol
1 Mayo Clin Proc
4 N Engl J Med
5 PLoS One
1 Psychosom Med


  Retrieve available abstracts of this week’s articles:
HTML format
 
 
Single Articles


    AJR Am J Roentgenol

  1. AGHAYEV A
    Editorial Comment: The Role of Artificial Intelligence-Guided Coronary CTA Interpretation in Coronary Artery Disease Management With Comparison to Myocardial Perfusion Imaging.
    AJR Am J Roentgenol. 2022 May 4. doi: 10.2214/AJR.22.27875.
    PubMed        


    Am Heart J

  2. REIFFEL JA
    The safety of flecainide for atrial fibrillation in patients with stable coronary artery disease - Fact or fallacy.
    Am Heart J. 2022;248:163-164.
    PubMed        


    Am J Cardiol

  3. WOODHEAD T, Matthews CJ, Blaxill JM, Greenwood JP, et al
    Meta-Analysis Comparing 10-Year Mortality Following Percutaneous Coronary Intervention or Coronary Artery Bypass Grafting in Left Main Stem or Multivessel Coronary Artery Disease.
    Am J Cardiol. 2022 Apr 30. pii: S0002-9149(22)00365.
    PubMed        

  4. AL-KINDI S, Tashtish N, Rashid I, Gupta A, et al
    Effect of No-Charge Coronary Artery Calcium Scoring on Cardiovascular Prevention.
    Am J Cardiol. 2022 Apr 26. pii: S0002-9149(22)00323.
    PubMed         Abstract available

  5. KRITTANAWONG C, Virk HUH, Isath A, Wang Z, et al
    Meta-Analysis of Brief Dual-Antiplatelet Therapy Duration After Percutaneous Coronary Intervention.
    Am J Cardiol. 2022 Apr 30. pii: S0002-9149(22)00354.
    PubMed        


    Am J Emerg Med

  6. FITZPATRICK N, Body R
    The derivation and validation of the Manchester Acute Coronary Syndrome Electrocardiograph model for the identification of non-ST-elevation myocardial ischaemia in the Emergency Department.
    Am J Emerg Med. 2022;57:27-33.
    PubMed         Abstract available


    Angiology

  7. HUANG L, He R, Sun X, Lv J, et al
    Association of Controlling Nutritional Status Score With Adverse Outcomes in Patients With Coronary Artery Disease: A Systematic Review and Meta-Analysis.
    Angiology. 2022 Apr 30:33197221094409. doi: 10.1177/00033197221094409.
    PubMed         Abstract available

  8. KANAL Y, Seyda Kanal HE, Yakut I, Ozen Y, et al
    CRP Albumin Ratio May Predict No Reflow in Patients Undergoing Percutaneous Coronary Intervention for Saphenous Vein Graft Stenosis.
    Angiology. 2022 May 2:33197221098277. doi: 10.1177/00033197221098277.
    PubMed         Abstract available

  9. BALCI MM, Balci KG, Ocak K, Ekici E, et al
    Predictive Value of Resting Fractional Flow Reserve and Atherogenic Index of Plasma for Evaluation of Physiologically Significant Coronary Artery Lesions.
    Angiology. 2022 May 2:33197221098280. doi: 10.1177/00033197221098280.
    PubMed         Abstract available

  10. OZBEYAZ NB, Gokalp G, Algul E, Sahan HF, et al
    H2FPEF Score and Contrast-Induced Nephropathy in Patients With Acute Coronary Syndrome Undergoing Percutaneous Coronary Intervention.
    Angiology. 2022 May 3:33197221099425. doi: 10.1177/00033197221099425.
    PubMed         Abstract available

  11. HE HM, He C, You ZB, Zhang SC, et al
    Prognostic Value of Different Versions of the Model for End-Stage Liver Disease Score in Patients Undergoing Percutaneous Coronary Intervention.
    Angiology. 2022 May 5:33197221098288. doi: 10.1177/00033197221098288.
    PubMed         Abstract available

  12. WANG Y, Zhao X, Zhou P, Liu C, et al
    High-Risk Culprit Plaque Predicts Cardiovascular Outcomes Independently of Plaque Rupture in ST-Segment Elevation Myocardial Infarction: Insight From Optical Coherence Tomography.
    Angiology. 2022 May 4:33197221087778. doi: 10.1177/00033197221087778.
    PubMed         Abstract available


    Ann Thorac Surg

  13. MOUCHLI AY, Chaugle H, Byrne JG
    Technique for Salvage Reconstruction of Shredded Left Main Coronary Artery after Rotablator Injury.
    Ann Thorac Surg. 2022 Apr 30. pii: S0003-4975(22)00665.
    PubMed         Abstract available

  14. YANG X, Jiang Y, Xie M, Wang X, et al
    Nongated computed tomography predicts perioperative cardiovascular risk in lung cancer surgery.
    Ann Thorac Surg. 2022 Apr 28. pii: S0003-4975(22)00637.
    PubMed         Abstract available


    Atherosclerosis

  15. KATSIKI N, Raggi P, Korosoglou G
    Carotid ultrasound and coronary calcium for the prediction of incident cardiac disease in asymptomatic individuals: A further step towards precision medicine especially in women?
    Atherosclerosis. 2022;346:79-81.
    PubMed        

  16. PASZEK E, Pociask E, Zabczyk M, Piorkowski A, et al
    Active factor XI is associated with the risk of cardiovascular events in stable coronary artery disease patients.
    Atherosclerosis. 2022 Feb 11. pii: S0021-9150(22)00078.
    PubMed         Abstract available

  17. YAMAGUCHI M, Hoshino M, Sugiyama T, Kanaji Y, et al
    Association of near-infrared spectroscopy-defined lipid rich plaque with lesion morphology and peri-coronary inflammation on computed tomography angiography.
    Atherosclerosis. 2022;346:109-116.
    PubMed         Abstract available

  18. MAURICIO R, Singh K, Sanghavi M, Ayers CR, et al
    Soluble Fms-like tyrosine kinase-1 (sFlt-1) is associated with subclinical and clinical atherosclerotic cardiovascular disease: The Dallas Heart Study.
    Atherosclerosis. 2022;346:46-52.
    PubMed         Abstract available

  19. CHO IY, Yoo JE, Han K, Kim D, et al
    Frequent drinking is more predictive of ischemic stroke than binge drinking, but not of myocardial infarction.
    Atherosclerosis. 2022;350:65-72.
    PubMed         Abstract available


    BMJ

  20. HAO Q, Aertgeerts B, Guyatt G, Bekkering GE, et al
    PCSK9 inhibitors and ezetimibe for the reduction of cardiovascular events: a clinical practice guideline with risk-stratified recommendations.
    BMJ. 2022;377:e069066.
    PubMed         Abstract available

  21. CRAM P, Hatfield LA, Bakx P, Banerjee A, et al
    Variation in revascularisation use and outcomes of patients in hospital with acute myocardial infarction across six high income countries: cross sectional cohort study.
    BMJ. 2022;377:e069164.
    PubMed         Abstract available

  22. KHAN SU, Yedlapati SH, Lone AN, Hao Q, et al
    PCSK9 inhibitors and ezetimibe with or without statin therapy for cardiovascular risk reduction: a systematic review and network meta-analysis.
    BMJ. 2022;377:e069116.
    PubMed         Abstract available


    Circ Heart Fail

  23. JORDA P, Martinez D, Farrero M, Marcos MA, et al
    BAG3 Genetic Cardiomyopathy May Overlap Fulminant Myocarditis Clinical Findings.
    Circ Heart Fail. 2022;15:e008443.
    PubMed        

  24. SINHA SS, Rosner CM, Tehrani BN, Maini A, et al
    Cardiogenic Shock From Heart Failure Versus Acute Myocardial Infarction: Clinical Characteristics, Hospital Course, and 1-Year Outcomes.
    Circ Heart Fail. 2022 May 5:101161CIRCHEARTFAILURE121009279.
    PubMed         Abstract available


    Circulation

  25. EMOTO T, Yamamoto H, Yamashita T, Takaya T, et al
    Single-Cell RNA Sequencing Reveals a Distinct Immune Landscape of Myeloid Cells in Coronary Culprit Plaques Causing Acute Coronary Syndrome.
    Circulation. 2022;145:1434-1436.
    PubMed        


    Crit Care Med

  26. MASSART N, Mansour A, Flecher E, Ross JT, et al
    Clinical Benefit of Extubation in Patients on Venoarterial Extracorporeal Membrane Oxygenation.
    Crit Care Med. 2022;50:760-769.
    PubMed         Abstract available

  27. BIDAUT A, Flecher E, Nesseler N, Bounader K, et al
    Outcome of Temporary Circulatory Support As a Bridge-to-Left Ventricular Assist Device Strategy in Cardiogenic Shock Patients.
    Crit Care Med. 2022;50:e426-e433.
    PubMed         Abstract available


    Eur Heart J

  28. FRANTZ S, Hundertmark MJ, Schulz-Menger J, Bengel FM, et al
    Left ventricular remodelling post-myocardial infarction: pathophysiology, imaging, and novel therapies.
    Eur Heart J. 2022 May 4. pii: 6578707. doi: 10.1093.
    PubMed         Abstract available


    Int J Cardiol

  29. WANG Z, Li T, Li M, Gu W, et al
    MALAT1 aggravates cardiomyocytes injury in myocardial infarction by sponging miR-135b.
    Int J Cardiol. 2022 Apr 29. pii: S0167-5273(22)00636.
    PubMed        

  30. LI J, Chen R, Zhou J, Wang Y, et al
    The relationship between Hemoglobin A1c and the maximal plaque stress of culprit ruptured plaques in patients with ST-segment elevated myocardial infarction.
    Int J Cardiol. 2022 Apr 29. pii: S0167-5273(22)00634.
    PubMed         Abstract available

  31. MAHABADI AA, Anapliotis V, Dykun I, Hendricks S, et al
    Epicardial fat and incident heart failure with preserved ejection fraction in patients with coronary artery disease.
    Int J Cardiol. 2022 Apr 5. pii: S0167-5273(22)00489.
    PubMed         Abstract available

  32. YAN H, Zhao N, Geng W, Hou Z, et al
    Pericoronary fat attenuation index and coronary plaque quantified from coronary computed tomography angiography identify ischemia-causing lesions.
    Int J Cardiol. 2022;357:8-13.
    PubMed         Abstract available

  33. KIM HO, Jiang B, Poon EKW, Thondapu V, et al
    High endothelial shear stress and stress gradient at plaque erosion persist up to 12 months.
    Int J Cardiol. 2022;357:1-7.
    PubMed         Abstract available

  34. HIGASHIOKA D, Shiono Y, Emori H, Khalifa AKM, et al
    Prevalence of myocardial perfusion scintigraphy derived ischemia in coronary lesions with discordant fractional flow reserve and non-hyperemic pressure ratios.
    Int J Cardiol. 2022;357:20-25.
    PubMed         Abstract available

  35. WANG W, Huang Q, Pan D, Zheng W, et al
    The optimal duration of triple antithrombotic therapy in patients with atrial fibrillation and acute coronary syndrome or undergoing percutaneous coronary intervention: A network meta-analysis of randomized clinical trials.
    Int J Cardiol. 2022 Mar 29. pii: S0167-5273(22)00441.
    PubMed         Abstract available


    J Am Coll Cardiol

  36. KELSEY MD, Nelson AJ, Green JB, Granger CB, et al
    Guidelines for Cardiovascular Risk Reduction in Patients With Type 2 Diabetes: JACC Guideline Comparison.
    J Am Coll Cardiol. 2022;79:1849-1857.
    PubMed         Abstract available

  37. COLANTONIO LD, Wang Z, Chen L, Mejia R, et al
    Trends in High-Intensity Statin Therapy After Myocardial Infarction Among U.S. Adults, 2011-2019.
    J Am Coll Cardiol. 2022;79:1870-1872.
    PubMed        


    J Cardiovasc Pharmacol

  38. DENNY O, Woodruff AE, Mills K, Chilbert MR, et al
    Comparison of ischemic and bleeding events between short versus long duration tirofiban regimens in patients with ST-segment elevation myocardial infarction undergoing percutaneous coronary intervention.
    J Cardiovasc Pharmacol. 2022 Apr 29. pii: 00005344-990000000-00037.
    PubMed         Abstract available

  39. BEAVERS CJ, Effoe SA, Dobesh PP
    Selatogrel: A Novel Subcutaneous P2Y12 Inhibitor.
    J Cardiovasc Pharmacol. 2022;79:161-167.
    PubMed         Abstract available

  40. SHANG YS, Zhong PY, Ma Y, Bai N, et al
    Efficacy and Safety of Proton Pump Inhibitors in Patients with Coronary Artery Diseases Receiving Oral Antiplatelet Agents and/or Anticoagulants: A Systematic Review and Meta-Analysis.
    J Cardiovasc Pharmacol. 2022 May 4. pii: 00005344-990000000-00036.
    PubMed         Abstract available

  41. HU MJ, Tan JS, Gao XJ, Yang JG, et al
    De-Escalation of Dual Antiplatelet Therapy after Percutaneous Coronary Intervention in Patients with Acute Coronary Syndrome: An Updated Meta-Analysis and Trial Sequential Analysis of 21 studies and 38741 patients.
    J Cardiovasc Pharmacol. 2022 Mar 4. pii: 00005344-990000000-00029.
    PubMed         Abstract available


    J Clin Epidemiol

  42. GROENHOF TKJ, Mostert M, Lea NC, Haitjema S, et al
    How Traditional Informed Consent Impairs Inclusivity in a Learning Healthcare System: Lessons Learned from the Utrecht Cardiovascular Cohort.
    J Clin Epidemiol. 2022 Apr 30. pii: S0895-4356(22)00114.
    PubMed        


    J Clin Invest

  43. GLINTON KE, Ma W, Lantz C, Grigoryeva LS, et al
    Macrophage-produced VEGFC is induced by efferocytosis to ameliorate cardiac injury and inflammation.
    J Clin Invest. 2022;132.
    PubMed         Abstract available


    J Electrocardiol

  44. ASLANGER EK
    Considerations on the naming of myocardial infarctions.
    J Electrocardiol. 2022;71:44-46.
    PubMed         Abstract available

  45. DOGNIN N, Steinberg C, Nault I, Sarrazin JF, et al
    Alternating morphology ventricular tachycardia associated with stable coronary artery disease: A case report.
    J Electrocardiol. 2022;71:40-43.
    PubMed         Abstract available

  46. SEDOVA KA, Demidova MM, Azarov JE, Hejda J, et al
    Terminal T-wave inversion predicts reperfusion tachyarrhythmias in STEMI.
    J Electrocardiol. 2022;71:28-31.
    PubMed         Abstract available

  47. MC LOUGHLIN MJ
    The significance of upright T wave in lead V1.
    J Electrocardiol. 2022;71:53.
    PubMed        

  48. UZUN HG, Simsek E, Mammadov G, Akilli A, et al
    Inferior ST-segment elevation due to metastatic cardiac tumor.
    J Electrocardiol. 2022;71:59-61.
    PubMed         Abstract available


    Mayo Clin Proc

  49. NAZIR S, Ariss RW, Khan Minhas AM, Ahuja KR, et al
    Outcomes of Patients With Type 2 Myocardial Infarction Complicating Acute Ischemic Stroke.
    Mayo Clin Proc. 2022 Apr 26. pii: S0025-6196(22)00002.
    PubMed         Abstract available


    N Engl J Med

  50. OZDEDE A, Yazici H
    Cardiovascular and Cancer Risk with Tofacitinib in Rheumatoid Arthritis.
    N Engl J Med. 2022;386:1766.
    PubMed        

  51. YTTERBERG SR, Bhatt DL, Connell CA
    Cardiovascular and Cancer Risk with Tofacitinib in Rheumatoid Arthritis. Reply.
    N Engl J Med. 2022;386:1768.
    PubMed        

  52. D'AMICO F, Peyrin-Biroulet L, Danese S
    Cardiovascular and Cancer Risk with Tofacitinib in Rheumatoid Arthritis.
    N Engl J Med. 2022;386:1767-1768.
    PubMed        

  53. LADAK K, Crowther M
    Cardiovascular and Cancer Risk with Tofacitinib in Rheumatoid Arthritis.
    N Engl J Med. 2022;386:1766-1767.
    PubMed        


    PLoS One

  54. NTIYANI N, Letamo G, Keetile M
    Prevalence of and factors associated with hypertension, diabetes, stroke and heart attack multimorbidity in Botswana: Evidence from STEPS 2014 survey.
    PLoS One. 2022;17:e0265722.
    PubMed         Abstract available

  55. SENGUTTUVAN NB, Reddy PMK, Shankar P, Abdulkader RS, et al
    Trans-radial approach versus trans-femoral approach in patients with acute coronary syndrome undergoing percutaneous coronary intervention: An updated meta-analysis of randomized controlled trials.
    PLoS One. 2022;17:e0266709.
    PubMed         Abstract available

  56. DOR-HAIM H, Horowitz M, Yaakobi E, Katzburg S, et al
    Intermittent aerobic-resistance interval training versus continues aerobic training: Improvement in cardiac electrophysiologic and anthropometric measures in male patients post myocadiac infarction, a randomized control trial.
    PLoS One. 2022;17:e0267888.
    PubMed         Abstract available

  57. JOSEPH J, Menon JC, Sebastien PK, Sudhakar A, et al
    Association of lipoprotein (a) with coronary artery disease in a South Asian population: A case-control study.
    PLoS One. 2022;17:e0267807.
    PubMed         Abstract available

  58. GROENLAND EH, Vendeville JP, Bots ML, de Borst GJ, et al
    The relation between urinary sodium and potassium excretion and risk of cardiovascular events and mortality in patients with cardiovascular disease.
    PLoS One. 2022;17:e0265429.
    PubMed         Abstract available


    Psychosom Med

  59. YI H, Li L, Wang Y, Tao H, et al
    The Potential Mediating Effects of Inflammation on the Association Between Type D Personality and Coronary Plaque Vulnerability in Patients With Coronary Artery Disease: An Optical Coherence Tomography Study.
    Psychosom Med. 2022;84:468-477.
    PubMed         Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Ischemic Heart Disease is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: